Hepion Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q2 2018 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2018 to Q1 2024.
  • Hepion Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.35K, a 87.3% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $11.5K, a 11.8% increase year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Interest Expense for 2023 was $9.47K, a 6.88% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Interest Expense for 2022 was $10.2K, a 14.7% increase from 2021.
  • Hepion Pharmaceuticals, Inc. annual Interest Expense for 2021 was $8.86K, a 71.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $11.5K $4.35K +$2.03K +87.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-21
Q4 2023 $9.47K $2.41K -$101 -4.02% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $9.57K $2.38K +$116 +5.12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $9.45K $2.35K -$827 -26% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $10.3K $2.32K +$113 +5.12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-21
Q4 2022 $10.2K $2.51K +$330 +15.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $9.83K $2.27K +$134 +6.29% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $9.7K $3.18K +$686 +27.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $9.01K $2.21K +$155 +7.55% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $8.86K $2.18K -$12.9K -85.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-10
Q3 2021 $21.7K $2.13K -$14K -86.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $35.8K $2.49K +$2.49K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $33.3K $2.05K +$2.05K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $31.2K $15.1K +$15.5K Oct 1, 2020 Dec 31, 2020 10-K 2022-04-08
Q3 2020 $15.7K $16.2K +$805 +5.24% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $14.9K $0 -$442K -100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $457K $0 -$98.3K -100% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $555K -$444 Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $15.4K -$40.1K -72.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $442K +$210K +90.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $98.3K Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q3 2018 $55.5K Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $232K Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.